m-PEG5-phosphonic acid enoside Rb3 and platelet aggregation

and platelet aggregation

Astragaloside IV inhibits the viability and invasive potential of MDA-MB-231 breast cancer cells

Urolithin C treatment actively increases the lactate dehydrogenase (LDH) release and lipid peroxidation malondialdehyde (MDA)

Smiles: C[C@H](N[C@@H](CCC1C=CC=CC=1)C(=O)OCC)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O

The number of chromosome aberrations in the bone marrow cells of treated mice does not differ significantly from the negative control group

m-PEG5-phosphonic acid enoside Rb3 and platelet aggregationm PEG5 phosphonic acid is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 1807512 39 5 Molecular Weight: 316. 29 Formula: C11H25O8P Chemical Name: (2,5,8,11,14 pentaoxahexadecan 16 yl)phosphonic acid Smiles: COCCOCCOCCOCCOCCP(O)(O)=O InChiKey: RCTDZLSRRJVKHJ UHFFFAOYSA N InChi: InChI=1S C11H25O8P c1 15 2 3 16 4 5 17 6 7 18 8 9 19 10 11 20(12,13)14 h2 11H2,1H3,(H2,12,13,14) Technical Data